Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kathrine Parker

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Clinical Kidney Journal|October 5, 2019
Is polypharmacy an increasing burden in chronic kidney disease? The German experienceKathrine Parker, Joanne Wong
British Journal of Haematology|September 6, 2018
The use of direct oral anticoagulants in chronic kidney diseaseKathrine Parker, Jecko Thachil
Nursing Standard (Royal College of Nursing (Great Britain) : 1987)|April 22, 2024
Impaired kidney function: supporting the safe use of medicines for patientsKathrine Parker, Janette Chu
Journal of Renal Care|October 13, 2012
Warfarin management in haemodialysis--are we meeting British Haematology Society standards?Kathrine Parker, Marc Vincent, Sandip Mitra
British Journal of Haematology|February 23, 2018
Is anticoagulating haemodialysis patients with non-valvular atrial fibrillation too risky?Kathrine Parker, Sandip Mitra, Jecko Thachil
The New England Journal of Medicine|June 10, 2026
Bleeding Risk with Apixaban vs. Rivaroxaban in Acute Venous ThromboembolismJohn Hartemink, Kathrine Parker, Sandip Mitra
Clinical Kidney Journal|April 11, 2015
Medication burden in CKD-5D: impact of dialysis modality and settingKathrine Parker, Milind Nikam, Anuradha Jayanti, et al.
Research and Practice in Thrombosis and Haemostasis|September 8, 2023
Thromboembolism in nephrotic syndrome: controversies and uncertaintiesKathrine Parker, Omar Ragy, Patrick Hamilton, et al.
BMC Nephrology|January 12, 2023
UK prescribing practice of anticoagulants in patients with chronic kidney disease: a nephrology and haematology-based surveyKathrine Parker, Satarupa Choudhuri, Penny Lewis, et al.
BMC Nephrology|January 28, 2025
Facilitating active participation in anticoagulant decisions in advanced kidney disease: co-production of a question prompt listKathrine Parker, Abigail Needham, Jecko Thachil, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Clinical Kidney Journal|October 5, 2019
Is polypharmacy an increasing burden in chronic kidney disease? The German experienceKathrine Parker, Joanne Wong
British Journal of Haematology|September 6, 2018
The use of direct oral anticoagulants in chronic kidney diseaseKathrine Parker, Jecko Thachil
Nursing Standard (Royal College of Nursing (Great Britain) : 1987)|April 22, 2024
Impaired kidney function: supporting the safe use of medicines for patientsKathrine Parker, Janette Chu
Journal of Renal Care|October 13, 2012
Warfarin management in haemodialysis--are we meeting British Haematology Society standards?Kathrine Parker, Marc Vincent, Sandip Mitra
British Journal of Haematology|February 23, 2018
Is anticoagulating haemodialysis patients with non-valvular atrial fibrillation too risky?Kathrine Parker, Sandip Mitra, Jecko Thachil
The New England Journal of Medicine|June 10, 2026
Bleeding Risk with Apixaban vs. Rivaroxaban in Acute Venous ThromboembolismJohn Hartemink, Kathrine Parker, Sandip Mitra
Clinical Kidney Journal|April 11, 2015
Medication burden in CKD-5D: impact of dialysis modality and settingKathrine Parker, Milind Nikam, Anuradha Jayanti, et al.
Research and Practice in Thrombosis and Haemostasis|September 8, 2023
Thromboembolism in nephrotic syndrome: controversies and uncertaintiesKathrine Parker, Omar Ragy, Patrick Hamilton, et al.
BMC Nephrology|January 12, 2023
UK prescribing practice of anticoagulants in patients with chronic kidney disease: a nephrology and haematology-based surveyKathrine Parker, Satarupa Choudhuri, Penny Lewis, et al.
BMC Nephrology|January 28, 2025
Facilitating active participation in anticoagulant decisions in advanced kidney disease: co-production of a question prompt listKathrine Parker, Abigail Needham, Jecko Thachil, et al.
Pageof 2